Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Into the Clinic With Nivolumab and Pembrolizumab.
Shu CA, Rizvi NA. Shu CA, et al. Oncologist. 2016 May;21(5):527-8. doi: 10.1634/theoncologist.2016-0099. Epub 2016 Mar 29. Oncologist. 2016. PMID: 27026678 Free PMC article.
PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
Heymann JJ, Bulman WA, Swinarski D, Pagan CA, Crapanzano JP, Haghighi M, Fazlollahi L, Stoopler MB, Sonett JR, Sacher AG, Shu CA, Rizvi NA, Saqi A. Heymann JJ, et al. Among authors: shu ca. Cancer Cytopathol. 2017 Dec;125(12):896-907. doi: 10.1002/cncy.21937. Epub 2017 Oct 12. Cancer Cytopathol. 2017. PMID: 29024471 Free article.
Combining chemotherapy with PD-1 blockade in NSCLC.
Mathew M, Enzler T, Shu CA, Rizvi NA. Mathew M, et al. Among authors: shu ca. Pharmacol Ther. 2018 Jun;186:130-137. doi: 10.1016/j.pharmthera.2018.01.003. Epub 2018 Jan 31. Pharmacol Ther. 2018. PMID: 29352857 Review.
Synchronous Pulmonary Adenocarcinomas.
Pagan CA, Shu CA, Crapanzano JP, Lagos GG, Stoopler MB, Rizvi NA, Heymann JJ, Sonett JR, Fernandes H, Saqi A. Pagan CA, et al. Among authors: shu ca. Am J Clin Pathol. 2020 Jun 8;154(1):57-69. doi: 10.1093/ajcp/aqaa023. Am J Clin Pathol. 2020. PMID: 32146481
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Shu CA, Gainor JF, Awad MM, Chiuzan C, Grigg CM, Pabani A, Garofano RF, Stoopler MB, Cheng SK, White A, Lanuti M, D'Ovidio F, Bacchetta M, Sonett JR, Saqi A, Rizvi NA. Shu CA, et al. Lancet Oncol. 2020 Jun;21(6):786-795. doi: 10.1016/S1470-2045(20)30140-6. Epub 2020 May 7. Lancet Oncol. 2020. PMID: 32386568 Clinical Trial.
38 results